HELMHOLTZ ZENTRUM FUR INFEKTIONSFORSCHUNG FUR DAS HELMHOLTZ INST FUR PHARMAZEUTISCHE FORSCHU GMBH PATENTS FACING OPPOSITIONS
Top patents of HELMHOLTZ ZENTRUM FUR INFEKTIONSFORSCHUNG FUR DAS HELMHOLTZ INST FUR PHARMAZEUTISCHE FORSCHU GMBH facing oppositions at the European Patent Office (EPO)
Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
EP3054993B1 |
04 Dec, 2019
|
Permanent Gene Correction By Means Of Nucleotide-Modified Messenger Rna
|
Oct, 2034
|
1
| |